Data-driven healthcare is proving that better insulin access leads to fewer long-term complications. Recent Human Insulin Market Data indicates that for every 10% increase in insulin adherence, there is a measurable decrease in hospitalizations for kidney failure and vision loss. These statistics are encouraging insurance providers to offer better coverage for advanced delivery devices, as the upfront cost is offset by lower long-term medical bills.

FAQ

• What is HbA1c? It is a blood test that shows a patient's average blood sugar levels over the past three months, often used to measure the success of insulin therapy.

• Does better insulin prevent complications? Yes, maintaining blood sugar within a target range significantly reduces the risk of nerve damage, heart disease, and kidney failure.